Profiles

Barbara de Graaff

Dr Barbara de Graaff

Barbara de Graaff

Senior Research Fellow (Health Economics)

Medical Science Precinct , Hobart CBD Campuses

61 3 6226 4262 (phone)

barbara.degraaff@utas.edu.au

Dr Barbara de Graaff is a Senior Research Fellow at the Menzies Institute for Medical Research. She is supported by the Dr Meredith Hodgson Research Fellowship. She completed her PhD in 2016 at the University of Tasmania on the health economics of HFE-haemochromatosis. Her research interests are focused on using large, linked health datasets to conduct population-level research.

Prior to commencing her PhD, Dr de Graaff worked as a Research Fellow at the School of Psychology, University of Tasmania. Her work focused on injecting drug use and harm reduction interventions. She has also held clinical and research roles with Turning Point Alcohol and Drug Centre (Melbourne, VIC), and Alcohol and Drug Services, Queensland Health.

Biography

Barbara completed her PhD at the Menzies Institute for Medical Research, University of Tasmania, where she investigated the health economic aspects of hereditary haemochromatosis. This work included the first quantification of the economic burden associated with hemochromatosis.

Expertise

* Health economics;

* Health policy;

* Primary health care;

* Viral hepatitis and liver cancer;

* Patient reported outcomes;

* Population and targeted screening programs;

* Chronic, complex conditions;

* HFE haemochromatosis;

* Idiopathic pulmonary fibrosis;

* Myalgic encephalomyelitis/chronic fatigue syndrome

Career summary

Qualifications

PhD: The Health Economics Aspects of Hereditary Haemochromatosis University of Tasmania Australia 2016

Memberships

Professional practice

Australian Health Economics Society

International Health Economics Association

Teaching

Teaching responsibility

Introduction to Health Economics

Health economic evaluations

Research Appointments

Board member of the Australian Health Economics Society

Convenor of the Australian Health Economics Society Doctoral Workshop

Member of the International Society for Pharmacoeconomics and Outcomes Research

View more on Dr Barbara de Graaff in WARP

Research Themes

Dr de Graaff’s research is strongly aligned with the University’s key theme of Better Health.

Awards

2020 Vice Chancellor’s Award for Outstanding Contribution in Response to COVID-19

2019 Visiting Fellow, University of Exeter

2017 University of Tasmania Career Development Scholarship

2017 Visiting Scholar at the Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne

Vice Chancellor’s Leadership Awards, 2013

Current projects

1. Evaluating the quality of life and health economic outcomes associated with idiopathic pulmonary fibrosis

2. Developing patient centred screening tools for hepatocellular carcinoma screening

3. Evaluating the clinical and health economic outcomes associated with new generation hepatitis C drugs

Fields of Research

Health economics (380108)
Health services and systems (420399)
Health psychology (520304)
Respiratory diseases (320103)
Health informatics and information systems (420308)
Behavioural neuroscience (520202)
Public health (420699)
Rheumatology and arthritis (320223)
Epidemiology (420299)
Primary health care (420319)
Health and community services (420305)
Health care administration (420306)
Disease surveillance (420202)
Mental health services (420313)
Health systems (420311)
Gastroenterology and hepatology (320209)
Endocrinology (320208)
Aged health care (420301)
Palliative care (420316)
Infectious diseases (320211)
Central nervous system (320903)
Aboriginal and Torres Strait Islander public health and wellbeing (450417)
Clinical pharmacology and therapeutics (321402)
Haematology (320102)
Haematological tumours (321106)
Paramedicine (320219)
Clinical sciences (320299)
Other psychology (529999)
Paediatrics (321399)
Cancer therapy (excl. chemotherapy and radiation therapy) (321104)
Genomics (310509)
Epidemiological modelling (420205)
Physiotherapy (420106)
Occupational therapy (420104)
Implementation science and evaluation (420312)
Pharmacology and pharmaceutical sciences (321499)
Health policy (440706)
Community and primary care (420503)
Cancer genetics (321103)
Environmental epidemiology (420203)
Aboriginal and Torres Strait Islander and disability (450401)
Health promotion (420603)
Cancer diagnosis (321102)
Aged care nursing (420502)
Major global burdens of disease (420207)
Solid tumours (321111)

Research Objectives

Public health (excl. specific population health) (200499)
Evaluation of health outcomes (200202)
Clinical health (200199)
Evaluation of health and support services (200299)
Health policy evaluation (200205)
Health system performance (incl. effectiveness of programs) (200206)
Diagnosis of human diseases and conditions (200101)
Health status (incl. wellbeing) (200407)
Preventive medicine (200412)
Expanding knowledge in psychology (280121)
Disease distribution and transmission (incl. surveillance and response) (200404)
Mental health (200409)
Other health (209999)
Mental health services (200305)
Behaviour and health (200401)
Specific population health (excl. Indigenous health) (200599)
Treatment of human diseases and conditions (200105)
Palliative care (200309)
Prevention of human diseases and conditions (200104)
Allied health therapies (excl. mental health services) (200301)
Health education and promotion (200203)
Inpatient hospital care (200304)
Health surveillance (200303)
Aboriginal and Torres Strait Islander health (210399)
Efficacy of medications (200102)
Primary care (200310)
Overweight and obesity (200411)
Expanding knowledge in the health sciences (280112)
Provision of health and support services (200399)
Aboriginal and Torres Strait Islander health system performance (210303)
Network systems and services (220105)
Nursing (200307)
Community health care (200302)

Publications

Total publications

112

Journal Article

(54 outputs)

Year	Citation	Altmetrics
2023	Roydhouse J, Connolly A, Daveson B, de Graaff B, Blanchard M, et al., 'Palliative care symptoms and problems in a culturally and linguistically diverse population: large retrospective cohort study', BMJ Supportive & Palliative Care pp. 1-10. ISSN 2045-435X (2023) [Refereed Article] DOI: 10.1136/spcare-2022-004111 [eCite] [Details] Co-authors: Roydhouse J Tweet
2022	Cai G, Jones G, Cicuttini FM, Wluka AE, Wang Y, et al., 'Study protocol for a randomised controlled trial of diacerein versus placebo to treat knee osteoarthritis with effusion-synovitis (DICKENS)', Trials, 23, (1) Article 768. ISSN 1745-6215 (2022) [Refereed Article] DOI: 10.1186/s13063-022-06715-w [eCite] [Details] Citations: Scopus - 1Web of Science - 1 Co-authors: Cai G; Jones G; Antony B; Thompson M; Winzenberg T; Buttigieg K; Aitken D Tweet
2022	Cox IA, Campbell J, de Graaff B, Otahal P, Corte TJ, et al., 'Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D', Quality of life research pp. 1-21. ISSN 1573-2649 (2022) [Refereed Article] DOI: 10.1007/s11136-022-03205-z [eCite] [Details] Co-authors: Cox IA; Campbell J; Otahal P; Walters EH; Palmer AJ Tweet
2022	Dinh HTT, de Graaff B, Campbell JA, Jose MD, Burgess JR, et al., 'Incremental healthcare expenditure attributable to diabetes mellitus: a cost of illness study in Tasmania, Australia', Diabetic Medicine, 39, (6) Article e14817. ISSN 0742-3071 (2022) [Refereed Article] DOI: 10.1111/dme.14817 [eCite] [Details] Citations: Scopus - 1Web of Science - 2 Co-authors: Dinh HTT; Campbell JA; Jose MD; Burgess JR; Saunder T; Kitsos A; Wiggins N; Palmer AJ Tweet
2022	Dinh NTT, Cox IA, de Graaff B, Campbell JA, Stokes B, et al., 'A comprehensive systematic review of data linkage publications on diabetes in Australia', Frontiers in Public Health, 10 Article 757987. ISSN 2296-2565 (2022) [Refereed Article] DOI: 10.3389/fpubh.2022.757987 [eCite] [Details] Co-authors: Dinh NTT; Cox IA; Campbell JA; Stokes B; Palmer AJ Tweet
2022	Dinh NTT, Cox IA, de Graaff B, Campbell JA, Stokes B, et al., 'A comprehensive systematic review of data linkage publications on diabetes in Australia', Frontiers in Public Health, 10 pp. 1-13. ISSN 2296-2565 (2022) [Refereed Article] DOI: 10.3389/fpubh.2022.757987 [eCite] [Details] Co-authors: Dinh NTT; Cox IA; Campbell JA; Stokes B; Palmer AJ Tweet
2022	Dinh NTT, de Graaff B, Campbell JA, Jose MD, Burgess J, et al., 'Costs of major complications in people with and without diabetes in Tasmania, Australia', Australian Health Review, 46, (6) pp. 667-678. ISSN 0156-5788 (2022) [Refereed Article] DOI: 10.1071/AH22180 [eCite] [Details] Co-authors: Dinh NTT; Campbell JA; Jose MD; Burgess J; Saunder T; Kitsos A; Wiggins N; Palmer AJ Tweet
2022	Dinh NTT, de Graaff B, Campbell JA, Jose MD, Burgess J, et al., 'Incremental healthcare expenditure attributable to diabetes mellitus: A cost of illness study in Tasmania, Australia', Diabetic Medicine, 39, (6) pp. 1-10. ISSN 0742-3071 (2022) [Refereed Article] DOI: 10.1111/dme.14817 [eCite] [Details] Citations: Scopus - 1Web of Science - 2 Co-authors: Dinh NTT; Campbell JA; Jose MD; Burgess J; Saunders T; Kitsos A; Wiggins N; Palmer AJ Tweet
2022	Nguyen ALT, Blizzard CL, Yee KC, Campbell JA, Palmer AJ, et al., 'Hospitalisation costs of primary liver cancer in Australia: evidence from a data-linkage study', Australian Health Review, 46, (4) pp. 463-470. ISSN 0156-5788 (2022) [Refereed Article] DOI: 10.1071/AH21395 [eCite] [Details] Co-authors: Nguyen ALT; Blizzard CL; Yee KC; Campbell JA; Palmer AJ Tweet
2022	Nguyen ALT, Blizzard CL, Yee KC, Palmer AJ, de Graaff B, 'Survival of primary liver cancer for people from culturally and linguistically diverse backgrounds in Australia', Cancer Epidemiology, 81 Article 102252. ISSN 1877-7821 (2022) [Refereed Article] DOI: 10.1016/j.canep.2022.102252 [eCite] [Details] Co-authors: Nguyen ALT; Blizzard CL; Yee KC; Palmer AJ Tweet
2022	Nguyen H, Yee KC, Braude M, Moldovan C, Cocker F, et al., 'Accuracy of coded cause of death data: a study based on primary liver cancer', Tasman Medical Journal, 4, (2) pp. 12-20. ISSN 2652-1881 (2022) [Refereed Article] [eCite] [Details] Co-authors: Nguyen H; Yee KC; Cocker F; Palmer AJ Tweet
2022	Orji NC, Campbell JA, Wills K, Hensher M, Palmer AJ, et al., 'Prevalence of myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) in Australian primary care patients: only part of the story?', BMC Public Health, 22 Article 1516. ISSN 1471-2458 (2022) [Refereed Article] DOI: 10.1186/s12889-022-13929-9 [eCite] [Details] Co-authors: Orji NC; Campbell JA; Wills K; Hensher M; Palmer AJ Tweet
2022	Xia Q, Campbell JA, Si L, Ahmad H, de Graaff B, et al., 'Healthcare resource utilisation and predictors for critical care unit admissions after primary bariatric surgery in an Australian public hospital setting: an exploratory study using a mixed-methods approach', Australian Health Review, 46, (1) pp. 42-51. ISSN 0156-5788 (2022) [Refereed Article] DOI: 10.1071/AH21251 [eCite] [Details] Citations: Scopus - 1Web of Science - 1 Co-authors: Xia Q; Campbell JA; Ahmad H; Palmer AJ Tweet
2022	Zheng Q, Cox IA, Campbell JA, Xia Q, Otahal P, et al., 'Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis', ERJ Open Research, 8, (1) Article 00591-2021. ISSN 2312-0541 (2022) [Refereed Article] DOI: 10.1183/23120541.00591-2021 [eCite] [Details] Citations: Scopus - 3Web of Science - 4 Co-authors: Cox IA; Campbell JA; Xia Q; Otahal P; Walters EH; Palmer AJ Tweet
2022	Zheng Q, Cox IA, de Graaff B, Campbell JA, Corte TJ, et al., 'The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument', Quality of Life Research Article online ahead of print. ISSN 0962-9343 (2022) [Refereed Article] DOI: 10.1007/s11136-022-03331-8 [eCite] [Details] Co-authors: Cox IA; Campbell JA; Ahmad H; Zhao T; Walters EH; Palmer AJ Tweet
2021	Cox IA, Otahal P, de Graaff B, Corte TJ, Moodley Y, et al., 'Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia', Respirology, 27, (3) pp. 209-216. ISSN 1323-7799 (2021) [Refereed Article] DOI: 10.1111/resp.14194 [eCite] [Details] Citations: Scopus - 6Web of Science - 6 Co-authors: Cox IA; Otahal P; Walters EH; Palmer AJ Tweet
2021	Cox IA, de Graaff B, Ahmed H, Campbell J, Otahal P, et al., 'The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from Australia', Quality of Life Research, 30, (9) pp. 2615-2632. ISSN 0962-9343 (2021) [Refereed Article] DOI: 10.1007/s11136-021-02879-1 [eCite] [Details] Citations: Scopus - 3Web of Science - 3 Co-authors: Cox IA; Ahmed H; Campbell J; Otahal P; Walters EH; Palmer AJ Tweet
2021	Cox IA, de Graaff B, Corte TJ, Glaspole I, Chambers DC, et al., 'Recent trends in pirfenidone and nintedanib utilisation for idiopathic pulmonary fibrosis in Australia', Australian Health Review, 45, (6) pp. 718-727. ISSN 0156-5788 (2021) [Refereed Article] DOI: 10.1071/AH20337 [eCite] [Details] Citations: Scopus - 2Web of Science - 2 Co-authors: Cox IA; Walters EH; Palmer AJ Tweet
2021	Hensher M, Angeles MR, de Graaff B, Campbell J, Athan E, 'Long COVID-19: threats, opportunities for health care system', InSight (2021) [Letter or Note in Journal] [eCite] [Details] Co-authors: Hensher M; Campbell J Tweet
2021	Palmer AJ, Campbell JA, de Graaff B, Devlin N, Ahmad H, et al., 'Population norms for quality adjusted life years for the United States of America, China, the United Kingdom and Australia', Health Economics pp. 1-28. ISSN 1057-9230 (2021) [Refereed Article] DOI: 10.1002/hec.4281 [eCite] [Details] Citations: Scopus - 5Web of Science - 5 Co-authors: Palmer AJ; Campbell JA; Ahmad H; Si L Tweet
2021	Xia Q, Campbell J, Si L, Ahmad H, de Graaff B, et al., 'Healthcare resource utilisation and predictors for critical care unit admissions after primary bariatric surgery in an Australian public hospital setting: an exploratory study using a mixed-methods approach', Australian Health Review ISSN 1449-8944 (2021) [Refereed Article] [eCite] [Details] Co-authors: Xia Q; Campbell J; Ahmad H; Marrone J; Kuzminov A; Palmer A
2021	Xia Q, Campbell JA, Ahmad H, de Graaff B, Si L, et al., 'Resource utilization and disaggregated cost analysis of bariatric surgery in the Australian public healthcare system', The European Journal of Health Economics ISSN 1618-7598 (2021) [Refereed Article] DOI: 10.1007/s10198-021-01405-x [eCite] [Details] Co-authors: Xia Q; Campbell JA; Ahmad H; Otahal P; Palmer AJ Tweet
2021	Zhao T, Winzenberg T, Aitken D, de Graaff B, Ahmad H, et al., 'The impact of comorbidities on health-related quality of life of people with osteoarthritis over 10 years', Rheumatology, 61, (1) pp. 139-145. ISSN 1462-0332 (2021) [Refereed Article] DOI: 10.1093/rheumatology/keab358 [eCite] [Details] Co-authors: Zhao T; Winzenberg T; Aitken D; Ahmad H; Jones Graeme; Palmer AJ Tweet
2020	Cox IA, Borchers Arriagada N, de Graaff B, Corte TJ, Glaspole I, et al., 'Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis', European Respiratory Review, 29 Article 200154. ISSN 0905-9180 (2020) [Refereed Article] DOI: 10.1183/16000617.0154-2020 [eCite] [Details] Citations: Scopus - 12Web of Science - 12 Co-authors: Cox IA; Borchers Arriagada N; Lartey S; Walters EH; Palmer AJ Tweet
2020	Cox IA, de Graaff B, Ahmed H, Campbell J, Otahal P, et al., 'The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study', The European Journal of Health Economics pp. 1-19. ISSN 1618-7601 (2020) [Refereed Article] DOI: 10.1007/s10198-022-01538-7 [eCite] [Details] Citations: Scopus - 1Web of Science - 2 Co-authors: Cox IA; Ahmed H; Campbell J; Otahal P; Walters EH; Palmer AJ Tweet
2020	Gardiner FW, de Graaff B, Bishop L, Campbell JA, Mealing S, et al., 'Mental health crises in rural and remote Australia: an assessment of direct medical costs of air medical retrievals and the implications for the societal burden', Air Medical Journal, 39, (5) pp. 343-350. ISSN 1067-991X (2020) [Refereed Article] DOI: 10.1016/j.amj.2020.06.010 [eCite] [Details] Citations: Scopus - 3 Co-authors: Campbell JA Tweet
2020	Lartey S, Si L, Lung T, Magnussen CG, Boateng GO, et al., 'Impact of overweight and obesity on life expectancy, quality-adjusted life years and lifetime costs in the adult population of Ghana', BMJ Global Health, 5, (9) Article e003332. ISSN 2059-7908 (2020) [Refereed Article] DOI: 10.1136/bmjgh-2020-003332 [eCite] [Details] Citations: Scopus - 5Web of Science - 3 Co-authors: Lartey S; Magnussen CG; Blizzard L; Palmer AJ Tweet
2020	Lartey ST, Si L, Otahal P, de Graaff B, Boateng GO, et al., 'Annual transition probabilities of overweight and obesity in older adults: evidence from World Health Organization Study on global AGEing and adult health', Social Science and Medicine, 247 Article 112821. ISSN 0277-9536 (2020) [Refereed Article] DOI: 10.1016/j.socscimed.2020.112821 [eCite] [Details] Citations: Scopus - 12Web of Science - 12 Co-authors: Lartey ST; Si L; Otahal P; Magnussen CG; Palmer AJ Tweet
2020	Nguyen AL, Nguyen HTT, Yee KC, Palmer AJ, Blizzard CL, et al., 'A systematic review and narrative synthesis of health economic evaluations of Hepatocellular Carcinoma (HCC) screening strategies', Value in Health pp. 1-11. ISSN 1098-3015 (2020) [Refereed Article] DOI: 10.1016/j.jval.2020.11.014 [eCite] [Details] Citations: Scopus - 3Web of Science - 3 Co-authors: Nguyen AL; Nguyen HTT; Yee KC; Palmer AJ; Blizzard CL Tweet
2020	Tran QN, Lambeth LG, Sanderson K, de Graaff B, Breslin M, et al., 'Trend of emergency department presentations with a mental health diagnosis in Australia by diagnostic group, 2004-05 to 2016-17', Emergency Medicine Australasia, 32, (2) pp. 190-201. ISSN 1742-6731 (2020) [Refereed Article] DOI: 10.1111/1742-6723.13451 [eCite] [Details] Citations: Scopus - 9Web of Science - 8 Co-authors: Tran QN; Lambeth LG; Sanderson K; Breslin M; Tran V; Neil AL Tweet
2020	Xia Q, Campbell JA, Ahmad H, Si L, de Graaff B, et al., 'Health state utilities for economic evaluation of bariatric surgery: a comprehensive systematic review and meta-analysis', Obesity Reviews, 21, (8) Article e13028. ISSN 1467-7881 (2020) [Refereed Article] DOI: 10.1111/obr.13028 [eCite] [Details] Citations: Scopus - 7Web of Science - 7 Co-authors: Xia Q; Campbell JA; Ahmad H; Si L; Otahal P; Palmer AJ Tweet
2020	Zhao T, Ahmad H, Winzenberg T, Aitken D, de Graaff B, et al., 'Cross-sectional and temporal differences in health-related quality of life of people with and without osteoarthritis: a 10-year prospective study', Rheumatology pp. 1-8. ISSN 1462-0324 (2020) [Refereed Article] DOI: 10.1093/rheumatology/keaa787 [eCite] [Details] Citations: Scopus - 3Web of Science - 3 Co-authors: Zhao T; Ahmad H; Winzenberg T; Aitken D; Jones G; Palmer AJ Tweet
2020	Zhao T, Ahmad H, de Graaff B, Xia Q, Winzenberg T, et al., 'A systematic review of the evolution of health-economic evaluation models of osteoarthritis', Arthritis Care & Research Article accepted manuscript. ISSN 2151-464X (2020) [Refereed Article] DOI: 10.1002/acr.24410 [eCite] [Details] Co-authors: Zhao T; Ahmad H; Xia Q; Winzenberg T; Aitken D; Palmer AJ Tweet
2020	Zhao T, Winzenberg T, de Graaff B, Aitken D, Ahmad H, et al., 'A systematic review and meta-analysis of health state utility values for osteoarthritis-related conditions', Arthritis Care & Research ISSN 2151-464X (2020) [Refereed Article] DOI: 10.1002/acr.24478 [eCite] [Details] Citations: Scopus - 2Web of Science - 2 Co-authors: Zhao T; Winzenberg T; Aitken D; Ahmad H; Palmer AJ Tweet
2019	Cocker F, Yee KC, Palmer AJ, de Graaff B, 'Increasing incidence and mortality related to liver cancer in Australia: time to turn the tide', Australian and New Zealand Journal of Public Health, 43, (3) pp. 267-273. ISSN 1753-6405 (2019) [Refereed Article] DOI: 10.1111/1753-6405.12889 [eCite] [Details] Citations: Scopus - 25Web of Science - 25 Co-authors: Cocker F; Yee KC; Palmer AJ Tweet
2019	Lartey ST, Magnussen CG, Si L, Boateng GO, de Graaff B, et al., 'Rapidly increasing prevalence of overweight and obesity in older Ghanaian adults from 2007-2015: evidence from WHO-SAGE Waves 1 & 2', PLoS One, 14, (8) Article e0215045. ISSN 1932-6203 (2019) [Refereed Article] DOI: 10.1371/journal.pone.0215045 [eCite] [Details] Citations: Scopus - 21Web of Science - 22 Co-authors: Lartey ST; Magnussen CG; Si L; Blizzard L; Palmer AJ Tweet
2019	Lartey ST, Magnussen CG, Si L, de Graaff B, Biritwum RB, et al., 'The role of intergenerational educational mobility and household wealth in adult obesity: evidence from wave 2 of the World Health Organization's study on global AGEing and adult health', PLoS ONE, 14, (1) Article e0208491. ISSN 1932-6203 (2019) [Refereed Article] DOI: 10.1371/journal.pone.0208491 [eCite] [Details] Citations: Scopus - 8Web of Science - 8 Co-authors: Lartey ST; Magnussen CG; Si L; Palmer AJ Tweet
2019	Lartey ST, Si L, de Graaff B, Magnussen CG, Ahmad H, et al., 'Evaluation of the association between health state utilities and obesity in sub-Saharan Africa: evidence from World Health Organization Study on Global AGEing and Adult Health Wave 2', Value in Health, 22, (9) pp. 1042-1049. ISSN 1098-3015 (2019) [Refereed Article] DOI: 10.1016/j.jval.2019.04.1925 [eCite] [Details] Citations: Scopus - 2Web of Science - 2 Co-authors: Lartey ST; Si L; Magnussen CG; Ahmad H; Campbell J; Palmer AJ Tweet
2019	Lartey ST, de Graaff B, Magnussen CG, Boateng GO, Aikins M, et al., 'Health service utilization and direct healthcare costs associated with obesity in older adult population in Ghana', Health Policy and Planning pp. 1-11. ISSN 0268-1080 (2019) [Refereed Article] DOI: 10.1093/heapol/czz147 [eCite] [Details] Citations: Scopus - 9Web of Science - 6 Co-authors: Lartey ST; Magnussen CG; Palmer AJ Tweet
2019	Tran QN, Lambeth LG, Sanderson K, de Graaff B, Breslin M, et al., 'Trends of emergency department presentations with a mental health diagnosis by age, Australia, 2004-05 to 2016-17: a secondary data analysis', Emergency Medicine Australasia, 31, (6) pp. 1064-1072. ISSN 1742-6731 (2019) [Refereed Article] DOI: 10.1111/1742-6723.13323 [eCite] [Details] Citations: Scopus - 8Web of Science - 8 Co-authors: Tran QN; Lambeth LG; Sanderson K; Breslin M; Tran V; Neil AL Tweet
2019	Tran QN, Lambeth LG, Sanderson K, de Graaff B, Breslin M, et al., 'Emergency department presentations with a mental health diagnosis in Australia, by jurisdiction and by sex, 2004-05 to 2016-17', Emergency Medicine Australasia pp. 1-10. ISSN 1742-6731 (2019) [Refereed Article] DOI: 10.1111/1742-6723.13438 [eCite] [Details] Citations: Scopus - 1Web of Science - 1 Co-authors: Tran QN; Lambeth LG; Sanderson K; Breslin M; Tran V; Neil AL Tweet
2019	Xia Q, Campbell JA, Ahmad H, Si L, de Graaff B, et al., 'Bariatric surgery is a cost-saving treatment for obesity - a comprehensive meta-analysis and updated systematic review of health economic evaluations of bariatric surgery', Obesity Reviews pp. 1-15. ISSN 1467-7881 (2019) [Refereed Article] DOI: 10.1111/obr.12932 [eCite] [Details] Citations: Scopus - 34Web of Science - 29 Co-authors: Xia Q; Campbell JA; Ahmad H; Si L; Palmer AJ Tweet
2018	Brissot P, Pietrangelo A, Adams PC, de Graaff B, McLaren CE, et al., 'Haemochromatosis', Nature Reviews. Disease Primers, 4 Article 18016. ISSN 2056-676X (2018) [Refereed Article] DOI: 10.1038/nrdp.2018.16 [eCite] [Details] Citations: Scopus - 173Web of Science - 175 Tweet
2018	de Graaff B, Yee KC, Clarke P, Palmer A, 'Uptake of and expenditure on direct-acting antiviral agents for Hepatitis C treatment in Australia', Applied Health Economics and Health Policy pp. 1-8. ISSN 1175-5652 (2018) [Refereed Article] DOI: 10.1007/s40258-018-0392-8 [eCite] [Details] Citations: Scopus - 7Web of Science - 5 Co-authors: Yee KC; Palmer A Tweet
2017	de Graaff B, Neil A, Sanderson K, Yee KC, Palmer AJ, 'Costs associated with hereditary haemochromatosis in Australia: a cost-of-illness study', Australian Health Review, 41, (3) pp. 254-267. ISSN 0156-5788 (2017) [Refereed Article] DOI: 10.1071/AH15188 [eCite] [Details] Citations: Scopus - 7Web of Science - 5 Co-authors: Neil A; Sanderson K; Yee KC; Palmer AJ Tweet
2017	de Graaff B, Neil A, Si L, Yee KC, Sanderson K, et al., 'Cost-effectiveness of different population screening strategies for hereditary haemochromatosis in Australia', Applied Health Economics and Health Policy, 15, (4) pp. 521-534. ISSN 1175-5652 (2017) [Refereed Article] DOI: 10.1007/s40258-016-0297-3 [eCite] [Details] Citations: Scopus - 8Web of Science - 9 Co-authors: Neil A; Si L; Yee KC; Sanderson K; Palmer AJ Tweet
2017	de Graaff B, Nelson M, Neil A, 'Up, up and away: The growth of after-hours MBS claims', Australian Family Physician, 46, (6) pp. 407-411. ISSN 0300-8495 (2017) [Refereed Article] PMID: 28609598 [eCite] [Details] Citations: Scopus - 5Web of Science - 6 Co-authors: Nelson M; Neil A Tweet
2017	de Graaff B, Si L, Neil AL, Yee KC, Sanderson K, et al., 'Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model', PharmacoEconomics - Open, 1, (1) pp. 37-51. ISSN 2509-4254 (2017) [Refereed Article] DOI: 10.1007/s41669-016-0005-0 [eCite] [Details] Citations: Scopus - 3 Co-authors: Si L; Neil AL; Yee KC; Sanderson K; Palmer AJ Tweet
2016	Neil A, de Graaff B, 'Need, want and demand: What is really happening with low-acuity presentations?', Emergency Medicine Australasia pp. 1-2. ISSN 1742-6731 (2016) [Letter or Note in Journal] DOI: 10.1111/1742-6723.12591 [eCite] [Details] Citations: Scopus - 1Web of Science - 1 Co-authors: Neil A Tweet
2016	de Graaff B, Neil A, Sanderson K, Yee KC, Palmer AJ, 'Quality of life utility values for hereditary haemochromatosis in Australia', Health and Quality of Life Outcomes, 14, (1) Article 31. ISSN 1477-7525 (2016) [Refereed Article] DOI: 10.1186/s12955-016-0431-9 [eCite] [Details] Citations: Scopus - 9Web of Science - 10 Co-authors: Neil A; Sanderson K; Yee KC; Palmer AJ Tweet
2015	de Graaff B, Neil A, Sanderson K, Si L, Yee KC, et al., 'A systematic review and narrative synthesis of health economic studies conducted for hereditary haemochromatosis', Applied Health Economics and Health Policy, 13, (5) pp. 469-483. ISSN 1175-5652 (2015) [Refereed Article] DOI: 10.1007/s40258-015-0189-y [eCite] [Details] Citations: Scopus - 8Web of Science - 7 Co-authors: Neil A; Sanderson K; Si L; Yee KC; Palmer AJ Tweet
2014	Si L, Winzenberg TM, de Graaff B, Palmer AJ, 'A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions', Osteoporosis International, 25, (8) pp. 1987-1997. ISSN 0937-941X (2014) [Refereed Article] DOI: 10.1007/s00198-014-2636-2 [eCite] [Details] Citations: Scopus - 68Web of Science - 66 Co-authors: Si L; Winzenberg TM; Palmer AJ Tweet
2012	Patel PK, Patel RP, Brandon S, McLean S, Bruno R, et al., 'Effects of Filtration on the Presence of Particulate and Oxycodone Content of Injections Prepared from Crushed OxyContin® Tablets', Current Drug Safety, 7, (3) pp. 218-224. ISSN 1574-8863 (2012) [Refereed Article] DOI: 10.2174/157488612803251298 [eCite] [Details] Citations: Scopus - 9 Co-authors: Patel RP; Brandon S; McLean S; Bruno R Tweet
2009	McLean SR, Bruno RB, Brandon S, de Graaff B, 'Effect of filtration on morphine and particle content of injections prepared from slow-release oral morphine tablets', Harm Reduction Journal, 6, (37) EJ ISSN 1477-7517 (2009) [Refereed Article] DOI: 10.1186/1477-7517-6-37 [eCite] [Details] Citations: Scopus - 20Web of Science - 20 Co-authors: McLean SR; Bruno RB; Brandon S Tweet

Chapter in Book

(1 outputs)

Year	Citation	Altmetrics
2022	de Graaff B, Cox I, 'Decision Making in the Context of Funding Cancer Therapy', Handbook of Quality of Life in Cancer, Springer, Cham, Angelos P. Kassianos (ed), London, pp. 223-233. ISBN 9783030847029 (2022) [Research Book Chapter] DOI: 10.1007/978-3-030-84702-9 [eCite] [Details] Co-authors: Cox I Tweet

Year

Citation

Altmetrics

2022

de Graaff B, Cox I, 'Decision Making in the Context of Funding Cancer Therapy', Handbook of Quality of Life in Cancer, Springer, Cham, Angelos P. Kassianos (ed), London, pp. 223-233. ISBN 9783030847029 (2022) [Research Book Chapter]

DOI: 10.1007/978-3-030-84702-9 [eCite] [Details]

Co-authors: Cox I

Review

(1 outputs)

Year	Citation	Altmetrics
2022	Dinh NTT, Cox IA, de Graaff B, Campbell JA, Stokes BC, et al., 'A comprehensive systematic review of data linkage publications on diabetes in Australia', Frontiers in Public Health, 10 pp. 757987. ISSN 2296-2565 (2022) [Substantial Review] DOI: 10.3389/fpubh.2022.757987 [eCite] [Details] Co-authors: Dinh NTT; Cox IA; Campbell JA; Stokes BC; Palmer AJ Tweet

Year

Citation

Altmetrics

2022

Dinh NTT, Cox IA, de Graaff B, Campbell JA, Stokes BC, et al., 'A comprehensive systematic review of data linkage publications on diabetes in Australia', Frontiers in Public Health, 10 pp. 757987. ISSN 2296-2565 (2022) [Substantial Review]

DOI: 10.3389/fpubh.2022.757987 [eCite] [Details]

Co-authors: Dinh NTT; Cox IA; Campbell JA; Stokes BC; Palmer AJ

Conference Publication

(30 outputs)

Year	Citation	Altmetrics
2022	Cox I, Campbell JA, de Graaff B, Corte TJ, Moodley Y, et al., 'P50 Comparison of the EQ-5D-5L and Aqol-8D in a cohort of people with idiopathic pulmonary fibrosis in Australia', The Future of HEOR in Patient-Driven Digital Healthcare Systems, 15-18 May 2022, Washington D.C, pp. S298. ISSN 1524-4733 (2022) [Conference Extract] DOI: 10.1016/j.jval.2022.04.065 [eCite] [Details] Co-authors: Cox I; Campbell JA; Walter HE; Palmer AJ Tweet
2022	Cox I, de Graaff B, Ahmad H, Campbell JA, Otahal P, et al., 'P43 The economic burden of idiopathic pulmonary fibrosis in Australia', The Future of HEOR in Patient-Driven Digital Healthcare Systems, 15-18 May 2022, Washington D.C, pp. S296. ISSN 1524-4733 (2022) [Conference Extract] DOI: 10.1016/j.jval.2022.04.056 [eCite] [Details] Co-authors: Cox I; Ahmad H; Campbell JA; Otahal P; Walter HE; Palmer AJ Tweet
2022	Dinh NTT, de Graaff B, Campbell JA, Jose MD, Burgess James, et al., 'Costs of major complications in people with and without diabetes in Tasmania, Australia', Abstracts of the 58th EASD Annual Meeting, 19-23 September 2022, Stockholm, Sweden, pp. 1-2. ISSN 1432-0428 (2022) [Conference Extract] DOI: 10.1007/s00125-022-05755-w [eCite] [Details] Citations: Scopus - 1 Co-authors: Dinh NTT; Campbell JA; Jose MD; Saunder T; Kitsos A; Wiggins Nadine; Palmer AJ Tweet
2022	Dinh Thi Thu Ngan, de Graaff B, Campbell JA, Jose MD, Burgess John, et al., 'EPH31 Risk of hospital admission or emergency department presentation due to diabetes complications: A retrospective cohort study in Tasmania, Australia', ISPOR Europe 2022 Abstracts, Values in Health Supplement, November 6-9, 2022, Vienna, Austria, pp. 197. ISSN 1098-3015 (2022) [Conference Extract] DOI: 10.1016/j.jval.2022.09.953 [eCite] [Details] Co-authors: Dinh Thi Thu Ngan; Campbell JA; Jose MD; Burgess John; Saunder THC; Kitsos AR; Otahal P; Palmer AJ Tweet
2022	Dinh Thi Thu Ngan, de Graaff B, Campbell JA, Palmer AJ, 'P55 Creating a web-based interactive map visualising the geographic variations of the burden of Diabetes to inform policymaking: an example from Tasmania, Australia', ISPOR Europe 2022 Abstracts, Values in Health Supplement, November 6-9, 2022, Vienna, Austria, pp. 13. ISSN 1098-3015 (2022) [Conference Extract] DOI: 10.1016/j.jval.2022.09.067 [eCite] [Details] Co-authors: Dinh Thi Thu Ngan; Campbell JA; Palmer AJ Tweet
2021	Cox IA, de Graaff B, Corte TJ, Glaspole I, Chambers DC, et al., 'Thoracic Society of Australia and New Zealand Annual Scientific Meeting 2021', Thoracic Society of Australia and New Zealand Annual Scientific Meeting 2021, 1 -2 May 2021, virtual, pp. 1-8. (2021) [Conference Extract] [eCite] [Details] Co-authors: Cox IA; Walters EH; Palmer AJ
2021	Xia Q, Campbell J, Ahmad H, de Graaff B, Si L, et al., 'Resource utilization and disaggregated cost analysis of bariatric surgery in the Australian public healthcare system', Value in Health ISSN 1098-3015 (2021) [Conference Extract] DOI: 10.1016/j.jval.2021.04.1130 [eCite] [Details] Co-authors: Xia Q; Campbell J; Ahmad H; Otahal P; Palmer A Tweet
2020	Black JA, Sharman J, Palmer A, de Graaff B, Hensher M, et al., 'Quality of life improves more for people who receive proactive absolute', Value in Health Regional Issues ISSN 2212-1099 (2020) [Conference Extract] [eCite] [Details] Co-authors: Sharman J; Palmer A; Otahal P; Nelson M; Campbell J
2020	Cox I, Borchers Arriagada N, de Graaff B, Corte T, Glaspole I, et al., 'Evaluation of health-related quality of life in IPF: A systematic review and meta-analysis', Respirology ISSN 1323-7799 (2020) [Conference Extract] [eCite] [Details] Co-authors: Cox I; Borchers Arriagada N; Lartey S; Walters H; Palmer A
2020	Cox I, de Graaff B, Ahmad H, Corte TJ, Walters HE, et al., 'The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from Australia', Value in Health Regional Issues ISSN 2212-1099 (2020) [Conference Extract] [eCite] [Details] Co-authors: Cox I; Ahmad H; Walters HE; Palmer A
2018	Lartey ST, Ahmad H, Si L, de Graaff B, Magnussen CG, et al., 'Health state utilities and high body mass index: evidence from WHO study of global ageing and adult health (SAGE)', Value in Health, pp. S109 (PSY20). (2018) [Conference Extract] [eCite] [Details] Co-authors: Lartey ST; Ahmad H; Si L; Magnussen CG; Palmer AJ
2016	de Graaff BL, Neil A, Sanderson K, Yee KC, Palmer AJ, 'PND9 - An Australian National Cost of Illness Study For Hereditary Haemochromatosis', Value in Health, pp. A874, 19 (7). ISSN 1098-3015 (2016) [Conference Extract] DOI: 10.1016/j.jval.2016.08.344 [eCite] [Details] Co-authors: Neil A; Sanderson K; Yee KC; Palmer AJ Tweet
2016	de Graaff BL, Si L, Neil A, Yee KC, Sanderson K, et al., 'PND10 - Cost-Effectiveness of Population Screening for Haemochromatosis In Australia: A State-Transition Model', Value in Health, pp. A874-A875, Vol 19 (7). ISSN 1098-3015 (2016) [Conference Extract] DOI: 10.1016/j.jval.2016.08.345 [eCite] [Details] Co-authors: Si L; Neil A; Yee KC; Sanderson K; Palmer AJ Tweet
2015	de Graaff BL, Neil A, Sanderson K, Yee KC, Palmer A, 'The impact of increasing severity of hereditary haemochromatosis on health state utility values', Value in Health, pp. A300, Vol 18, A1-A307. ISSN 1098-3015 (2015) [Conference Extract] [eCite] [Details] Co-authors: Neil A; Sanderson K; Yee KC; Palmer A
2012	de Graaff B, Bruno RB, 'The correlates of financial strain amongst people who inject drugs', Drug and Acohol Review, 18-21 November 2012, Melbourne, Victoria, pp. 54. ISSN 0959-5236 (2012) [Conference Extract] [eCite] [Details] Co-authors: Bruno RB
2012	de Graaff B, Bruno RB, 'Experience of non-viral injecting-related injuries and diseases amongst people who regularly inject drugs', Drug and Alcohol Review, 18-21 November 2012, Melbourne, Victoria, pp. 55. ISSN 0959-5236 (2012) [Conference Extract] [eCite] [Details] Co-authors: Bruno RB
2011	Wake C, Bruno RB, Siddall D, de Graaff B, Donaldson F, et al., 'Health and Well-Being in Tasmanian Prisoners With and Without Hepatitis C Antibodies', Drug and Alcohol review, 13-16 November 2011, Hobart, Australia, pp. 88. ISSN 0959-5236 (2011) [Conference Extract] [eCite] [Details] Co-authors: Bruno RB
2011	de Graaff B, Bruno RB, Wake C, 'NPS provision in prisons: Time to embrace the evidence', Drug and Alcohol Review, 13-16 November 2011, Hobart, Australia, pp. 24. ISSN 0959-5236 (2011) [Conference Extract] [eCite] [Details] Co-authors: Bruno RB
2010	Cassar J, de Graaff B, Phillips B, Nielsen S, Bruno RB, et al., 'Over the counter codeine use by people who inject drugs regularly in Australia', Drug and Alcohol Review, 28 November-1 December 2010, Canberra, Australia, pp. A11. (2010) [Conference Extract] [eCite] [Details] Co-authors: Bruno RB
2010	Ebert R, Bruno RB, Matthews AJ, de Graaff B, 'Predictors of sub-clinical paranoia among methamphetamine consumers', Drug and Alcohol Review, 28 November-1 December 2010, Canberra, Australia, pp. A24. (2010) [Conference Extract] [eCite] [Details] Co-authors: Ebert R; Bruno RB; Matthews AJ
2010	McLean SR, Brandon S, Bruno RB, de Graaff B, Patel RP, 'Reducing harm from pharmaceutical opioid injection: The importance and effectiveness of filters', Drug and Alcohol Review, 28 November -1 December 2010, Canberra, Australia, pp. A51. (2010) [Conference Extract] [eCite] [Details] Co-authors: McLean SR; Brandon S; Bruno RB; Patel RP
2010	McLean SR, Brandon S, de Graaff B, Bruno RB, Patel RP, 'Injecting OxyContin: What is the harm reduction eveidence?', Proceedings of ATDC 2010, 18-20 October 2010, Hobart, pp. 1. (2010) [Conference Extract] [eCite] [Details] Co-authors: McLean SR; Brandon S; Bruno RB; Patel RP
2010	de Graaff B, Bruno RB, 'Old fits, new fits: Re-use of injecting equipment amongst a sample of regular injectiing drug users in Tasmania', Drug and Alcohol Review, 28 November-1 December 2010, Canberra, Australia, pp. A17-18. (2010) [Conference Extract] [eCite] [Details] Co-authors: Bruno RB
2010	de Graaff B, Bruno RB, 'Alprazolam use in Tasmania: Is policy change kicking goals or behinds?', Drug and Alcohol Review, 28 November-1 December 2010, Canberra, Australia, pp. A17. (2010) [Conference Extract] [eCite] [Details] Co-authors: Bruno RB
2009	Bruno RB, Gomez R, Fry C, Stoove M, de Graaff B, 'The blood borne virus transmission risk assessment questionnaire (short version): Can it identify risk equivalently for heroin, methamphetamine and pharmaceutical opioid injectors?', Drug and Alcohol Review, 1-4 November 2009, Darwin, pp. A6-A7. (2009) [Conference Extract] [eCite] [Details] Co-authors: Bruno RB; Gomez R
2009	Bruno RB, McLean SR, Brandon S, de Graaff B, Murray N, 'Injecting MS Contin: What is the harm reduction evidence?', Drug and Alcohol Review, 1-4 November 2009, Darwin, pp. A69. (2009) [Conference Extract] [eCite] [Details] Co-authors: Bruno RB; McLean SR; Brandon S
2009	Bruno RB, de Graaff B, 'Bumps, bruises and benzos: Factors associated with accidents amongh regular injecting drug users', Drug and Alcohol Review, 1-4 November 2009, Darwin, pp. A6. (2009) [Conference Extract] [eCite] [Details] Co-authors: Bruno RB
2008	Bruno RB, Murray N, McLean SR, de Graaff B, Brandon S, 'Filtering pharmaceutical opioids for injection: What methods are being used and how effective are they?', APSAD, 23-26 November 2008, Sydney, NSW, pp. 86. (2008) [Conference Edited] [eCite] [Details] Co-authors: Bruno RB; McLean SR; Brandon S
2008	Bruno RB, de Graaff B, 'Pull the other one: Effects of the prescription restriction level for benzodiazepines in an isolated drug market', APSAD, 23-26 November 2008, Sydney, NSW, pp. 37. (2008) [Conference Edited] [eCite] [Details] Co-authors: Bruno RB
2008	de Graaff B, Bruno RB, Snidicich N, 'Pharmaceutical opioid injection in high and low heroin availability jurisdictions: the who and why', APSAD, 23-26 November 2008, Sydney, NSW, pp. 77. (2008) [Conference Edited] [eCite] [Details] Co-authors: Bruno RB

Contract Report, Consultant's Report

(14 outputs)

Year	Citation	Altmetrics
2015	Peacock A, de Graaff B, Bruno RB, 'Tasmanian drug trends 2014. Findings from the Illicit Drug Reporting System (IDRS). Australian Drug Trends Series No. 131', National Drug and Alcohol Research Centre, Australia, 131 (2015) [Contract Report] [eCite] [Details] Co-authors: Peacock A; Bruno RB
2013	de Graaff B, Bruno RB, 'Tasmania Drug Trends 2012: Findings from the Illicit Drug Reporting System (IDRS)', Australian Government Department of Health and Ageing, 77 (2013) [Contract Report] [eCite] [Details] Co-authors: Bruno RB
2012	de Graaff B, Bruno RB, 'Tasmanian Drug Trends 2011: Findings from the Illicit Drug Reporting System (IDRS)', Australian Government Department of Health and Ageing, Sydney, 77 (2012) [Contract Report] [eCite] [Details] Co-authors: Bruno RB Tweet
2011	de Graaff B, Bruno RB, 'Tasmanian Drug Trends 2010: Findings from the Illicit Drug Report System (IDRS)', Australian Government Department of Health and Aging, Sydney, 59 (2011) [Contract Report] [eCite] [Details] Co-authors: Bruno RB Tweet
2010	de Graaff B, Bruno RB, 'Tasmanian Drug Trends 2009: Findings from the Illicit Drug Reporting System (IDRS)', National Drug and Alcohol Research Centre, Sydney, 41 (2010) [Contract Report] [eCite] [Details] Co-authors: Bruno RB Tweet
2010	de Graaff B, Bruno RB, 'The Health and Wellbeing of a Group of Tasmanian Regular Injecting Drug Users', National Drug and Alcohol Research Centre (2010) [Contract Report] [eCite] [Details] Co-authors: Bruno RB
2009	de Graaff B, Bruno RB, 'Tasmanian Drug Trends 2008: Findings from the Illicit Drug Reporting System (IDRS)', Australian Government Department of Health and Ageing, Sydney (2009) [Contract Report] [eCite] [Details] Co-authors: Bruno RB
2008	Black E, Roxburgh A, Degenhardt L, Bruno RB, Campbell G, et al., 'Australian Drug Trends 2007: Findings from the Illicit Drug Reporting System', Australian Government Department of Health and Ageing, Sydney, 978-0-7334-2625-4 (2008) [Contract Report] [eCite] [Details] Co-authors: Bruno RB Tweet
2008	de Graaff B, Bruno RB, 'Tasmanian Drug Trends 2007: Findings from the Ilicit Drug Reporting System (IDRS)', Australian Government Department of Health and Ageing, Sydney (2008) [Contract Report] [eCite] [Details] Co-authors: Bruno RB
2007	Bruno RB, Ong SY, de Graaff B, 'Indicators of Drug Use in Tasmania', Tasmanian State Government - Department of Health and Human Services (2007) [Consultants Report] [eCite] [Details] Co-authors: Bruno RB; Ong SY
2007	O'Brien S, Black E, Degenhardt L, Roxburgh A, Campbell G, et al., 'Australian Drug Trends 2006: Findings from the Illicit Drug Reporting System', Australian Government Department of Health and Ageing; National Drug Law Enforcement Research Fund, 60 (2007) [Contract Report] [eCite] [Details]
2007	de Graaff B, Bruno RB, 'Tasmanian Drug Trends 2006: Findings from the Illicit Drug Reporting System (IDRS)', Australian Government Department of Health and Aging; National Drug Law Enforcement Research Fund, 273 (2007) [Contract Report] [eCite] [Details] Co-authors: Bruno RB
2007	de Graaff B, Bruno RB, 'Self-reported mental health problems amongst regular injecting drug users interviewed in the IDRS', Australian Government Department of Health and Aging (2007) [Contract Report] [eCite] [Details] Co-authors: Bruno RB
2007	de Graaff B, Bruno RB, 'Tasmanian Drug Trends 2006: Findings from the Illicit Drug Reporting System and Extension Study (IDRS-E)', Tasmanian State Government Department of Health and Human Services (2007) [Contract Report] [eCite] [Details] Co-authors: Bruno RB

Thesis

(1 outputs)

Year	Citation	Altmetrics
2016	de Graaff B, 'The Health Economics of Haemochromatosis' (2016) [PhD] [eCite] [Details]

Other Public Output

(11 outputs)

Year	Citation	Altmetrics
2021	Hensher M, Angeles MR, de Graaff B, Campbell J, Athan E, et al., 'Managing the long term health consequences of COVID-19 in Australia', Deeble Institute for Health Policy Research, Australia (2021) [Government or Industry Research] [eCite] [Details] Co-authors: Campbell J
2021	Hensher M, Angeles MR, de Graaff B, Campbell JA, Athan E, et al., 'Managing the long term health consequences of COVID-19 in Australia', Deeble Institute Issues Brief, Australian Healthcare and Hospitals Association, Australia, 40 (2021) [Government or Industry Research] [eCite] [Details] Co-authors: Campbell JA
2020	Gardiner FW, Bishop L, de Graaff B, Campbell JA, Quinlan F, 'Equitable patient access to primary healthcare in Australia', The Royal Flying Doctor Service of Australia, Canberra, Australia (2020) [Report Other] [eCite] [Details] Co-authors: Campbell JA
2019	Doherty B, Nash R, Elmer S, Campbell J, Julian R, et al., 'Lead Support Coordinator Service (LSCS) Evaluation Report', Prepared for the Department of Communities, Tasmania, Australia (2019) [Report of Restricted Access] [eCite] [Details] Co-authors: Doherty B; Nash R; Elmer S; Campbell J; Julian R; Vandenberg M; West S; Palmer A
2017	de Graaff B, Makin J, Neil A, Nelson M, 'Tasmanian After-Hours Primary Care: Evaluation of the GP Assist Service 2017', Primary Health Tasmania, Australia (2017) [Report of Restricted Access] [eCite] [Details] Co-authors: Makin J; Neil A; Nelson M
2017	de Graaff B, Nelson MR, 'After-hours GP home visits strain the budget (and don't help emergency departments)', The Conversation (2017) [Magazine Article] [eCite] [Details] Co-authors: Nelson MR Tweet
2016	Neil A, de Graaff B, Chappell K, Sanderson K, Palmer A, et al., 'What Value GP Assist? The comparative benefits of, and satisfaction with GP Assist in Residential Aged Care Facilities and General Practice in Rural and Urban Tasmania', Department of Health and Human Services, Tasmanian Government, Tasmania (2016) [Report of Restricted Access] [eCite] [Details] Co-authors: Neil A; Chappell K; Sanderson K; Palmer A; Nelson M
2016	Neil A, de Graaff B, Nelson M, Chappell K, Palmer A, et al., 'Tasmanian After-Hours Primary Care Service Innovations: A Report in Three Parts', Primary Health Tasmania, Australia (2016) [Report of Restricted Access] [eCite] [Details] Co-authors: Neil A; Nelson M; Chappell K; Palmer A; Sanderson K
2014	Peacock A, de Graaff B, Bruno RB, 'Barriers to Harm Reduction: Heating and Filtration of Oxycodone Tablets Prior to Intravenous Use by People Who Inject Drugs in Australia', Drug Trends Bulletin, National Drug and Alcohol Research Centre, University of New South Wales, Australia, Australia, April 2014 (2014) [Government or Industry Research] [eCite] [Details] Co-authors: Peacock A; Bruno RB
2014	de Graaff B, Peacock A, Bruno RB, 'Tasmanian drug trends 2013. Findings from the Illicit Drug Reporting System (IDRS)', Australian Drug Trends Series No. 113, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, pp. 1-194. (2014) [Government or Industry Research] [eCite] [Details] Co-authors: Peacock A; Bruno RB
2011	de Graaff B, 'Push to fight jail hepatitis', The Mercury, Hobart, 28 November 2011, p. 13. (2011) [Newspaper Article] [eCite] [Details]

Grants & Funding

Funding Summary

Number of grants

Total funding

$5,166,986

Projects

Identifying Advanced Liver Fibrosis in Primary Care (2023 - 2025)$2,550,696

Description: Chronic liver disease effects 1 in 4 Australians and may lead to advanced liver fibrosis which is typically asymptomatic and not detected by routine tests. Under-recognition of advanced liver fibrosis precludes the opportunity for risk-stratification, treatment, preventative and surveillance strategies to reduce morbidity. Despite the availability of accurate liver fibrosis tests, there is a lack of implementation in primary care where the bulk of liver disease exists. To overcome this, we will assess the real-world effectiveness, cost and implementation context of an integrated liver fibrosis detection pathway in at-risk patients in primary care. This will be examined via a multi-centre cluster RCT of 42 urban and rural general practices randomly assigned to usual care or a liver fibrosis detection pathway. This will consist of a patient identification and diagnostic pathway, integrated into GP practice management software and aided by a decision support system. The efficacy endpoint will be the proportion of patients with risk factors for chronic liver disease with newly diagnosed advanced liver fibrosis at 12 months. We will also determine the cost-effectiveness of our approach in reducing liver-related mortality, and the implementation context by performing a process evaluation using the RE-AIM framework in order to guide rapid translation into clinical care. We will provide evidence for clinical pathway development and real-world cost-effectiveness data which is critical for adoption and funding. The intervention consists of current technology incorporated into existing software platforms, supporting a rapid implementation. Moreover, the process evaluation will provide the platform to maximise successful implementation strategies in the future. Our collaborative multi-disciplinary team is well-placed to translate our findings and influence government policy to enable wide-spread implementation.
Funding: Medical Research Future Fund ($2,550,696)
Scheme: Grant-Clinical Trial Activity Initiative
Administered By: University of Tasmania
Research Team: Adams L; de Graaff B; Nguyen AL
Period: 2023 - 2025

Providing high-value care for osteoarthritis patients at the Royal Hobart Hospital (RHH) (2022)$24,943

Description: GLA:D is an international evidence-based education and exercise program for people with knee and hip osteoarthritis. This project will evaluate the implementation of GLA:D through the RHH physiotherapy community outpatient clinics for patients on a joint replacement surgery pathway. It will benefit patients and potentially reduce pressure on elective surgery waiting lists.
Funding: Royal Hobart Hospital Research Foundation ($24,943)
Scheme: Grant-Project
Administered By: University of Tasmania
Research Team: Aitken D; Lawler K; Harvie P; O'Brien L; Barton C; Hyland P; de Graaff B; Van Dam PJ; Peterson GM; Collins N; Jones G
Year: 2022

The health economic impacts of residential fires on the Tasmanian public healthcare system 2010 to 2020 using a mixed-methods approach (2022)$9,945

Description: This is the first collaboration between the Tasmanian Fire Service and the Menzies Institute for Medical Research. Using linked data, this project will investigate epidemiological profiles and health services utilisation regarding residential house fires in Tasmania from 2010 to 2020.
Funding: Royal Hobart Hospital Research Foundation ($9,945)
Scheme: Grant-Incubator
Administered By: University of Tasmania
Research Team: Dinh T; Campbell JA; Palmer AJ; Schrale RB; Ratcliffe K; Orr F; King L; Barber S; de Graaff B
Year: 2022

The right to rehabilitation for people with dementia: tackling stigma and implementing evidence-based interventions (2022)$1,015,820

Description: Dementia is one of the major causes of disability in older people. The World Health Organization recognises that rehabilitation may be needed by anyone with a disability (not just after an acute event) including people with dementia. Our team has led the field internationally showing that rehabilitation and reablement can maintain independence and quality of life, but also importantly, reduce care partner stress. However, evidence-based interventions are often denied. This project will move from generating evidence to implementation, ensuring that people with dementia have equal access to quality health care in order to live at home for as long as possible.The overall aim of our study is to co-design and evaluate a program of solutions (INCLUDE) to improve access to rehabilitation and reablement treatments for vulnerable people living with dementia in the community. We will do so by: 1) reducing stigma and ensuring health workers have the knowledge to provide clients with early referral and care tailored to their needs, 2) empowering people with dementia and their care partner to ask for such interventions and 3) promote systematic collaboration between primary care, providers and dementia services, as well as a community of practice to facilitate referral pathways and learnings. The output of this project will be a package of freely available solutions to improve access to evidence-based rehabilitation treatments for people with dementia to improve their function and quality of life.
Funding: Medical Research Future Fund ($1,015,820)
Scheme: Grant - Dementia, Ageing and Aged Care Mission
Administered By: Monash University
Research Team: Callisaya M; de Graaff B
Year: 2022

Eliminating hepatitis B in remote Indigenous settings: generating health economic evidence (2022 - 2025)$750,738

Description: Chronic hepatitis B (CHB) is endemic across Indigenous communities in the Northern Territory (NT), with prevalence between 2-5%. Of this group, up to 25% will die from decompensated cirrhosis or liver cancer without care and treatment. In turn, liver disease is the third leading factor contributing to the gap in life expectancy between Indigenous and non-Indigenous Australians.In 2017 the NHMRC funded the Hep B PAST Partnership Project (GNT1151837), which aims to eliminate CHB from NT Indigenous Australians. This is being achieved through two mechanisms: improvement of CHB health literacy amongst participating Indigenous communities and healthcare providers; and transition of CHB care to a primary healthcare based, co-ordinated chronic disease model supported by the establishment of a CHB clinical register.The preliminary results of the Hep B PAST Project have demonstrated a highly effective model of care to increase rates of CHB diagnosis, treatment and community education. The Hep B PAST Project will be completed in mid-2023. To successfully eliminate hepatitis B, it is now critically important to transition this care model Territory-wide. Health economic evidence is now required by government to support this. We have developed five studies to generate this evidence:1: Quantify costs of the Hep B PAST model of care and the status quo approach to CHB care;2: Quantify quality of life/health state utility values for hepatitis B health states;3. Develop and validate a health economic disease simulation model for hepatitis B forIndigenous communities;4: Project clinical outcomes of the Hep B PAST model of care and the status quo up to 2035;5: Assess the cost-effectiveness of introducing the Hep B PAST model of care as standardpractice across the NT.We will develop the first Indigenous-specific health economic model that will be made available to support rapid, robust evaluations to introduce Hep B PAST into other states/territories.
Funding: National Health & Medical Research Council ($750,738)
Scheme: Grant-Ideas
Administered By: University of Tasmania
Research Team: de Graaff B; Cowie Ben; Campbell JA; Wills KE; Stephens N; Palmer AJ
Period: 2022 - 2025
Grant Reference: 2012285

Lung cancer screening in Tasmania (2022)$24,945

Description: Tasmania has the second highest rate of lung cancer incidence and mortality in Australia. This project will evaluate risk models for identification of high-risk candidates for lung cancer screening and assess whether a screening programme can be effectively and economically implemented. This will lead to earlier identification and treatment, with higher survival rates for Tasmanians, with potential for cost savings.
Funding: Royal Hobart Hospital Research Foundation ($24,945)
Scheme: Grant-Project
Administered By: University of Tasmania
Research Team: Palmer AJ; Harkness N; de Graaff B; Walters EH; Cox IA
Year: 2022

Prevalence, incidence, risk profiles, and health impacts of residential fires in Tasmania 2010-2020 (2021 - 2022)$30,000

Description: This is the first collaboration between the Tasmanian Fire Service and the Menzies Institute for Medical Research. Using linked data, this project will investigate epidemiological profiles and health services utilisation regarding residential house fires in Tasmania from 2010 to 2020.
Funding: Tasmania Fire Service ($30,000)
Scheme: Contract Research
Administered By: University of Tasmania
Research Team: Campbell JA; Palmer AJ; de Graaff B
Period: 2021 - 2022

Using data linkage to estimate the burden of diabetes in Tasmania (2021)$24,969

Description: Using pathology, hospital, emergency department, and mortality data linked from four different datasets in Tasmania, this project will quantify the health economic burden associated with diabetes for the Tasmanian Health System, and identifying potential factors that may be targeted for improved patient outcomes and/or cost savings to government.
Funding: Royal Hobart Hospital Research Foundation ($24,969)
Scheme: Grant-Project
Administered By: University of Tasmania
Research Team: Palmer AJ; Jose M; de Graaff B; Campbell JA
Year: 2021

NAFLD- screen (Non-alcoholic fatty liver disease: prevalence and screening for type 2 diabetes patients) (2020)$24,999

Description: This study will assess the prevalence of non-alcohol fatty liver disease (NAFLD) in patients with type 2 diabetes and normal liver function tests attending the Royal Hobart Hospital Diabetes Outpatient Clinic. It will further assess the most cost-effective strategy for targeted screening for this patient group.
Funding: Royal Hobart Hospital Research Foundation ($24,999)
Scheme: Grant-Project
Administered By: University of Tasmania
Research Team: de Graaff B; Yee KC; Campbell JA; Palmer AJ; Lartey ST; McCallum R; Wilson MD
Year: 2020

Screening for liver cancer in primary care: a systematic review of the evidence (2020 - 2021)$0

Description: The project seeks to review the evidence relating to screening for liver cancer in primary care. In particular, we will seek to identify barriers and facilitators to screening for both patients and providers. The goal of this project is to summarise the evidence in the field, which can provide a basis for customised interventions to improve screening uptake.
Funding: Primary Care Collaborative Cancer Clinical Trials Group ($0)
Scheme: Award - Training Award
Administered By: University of Tasmania
Research Team: de Graaff B; Roydhouse J
Period: 2020 - 2021

Association between bush fire-smoke/wood-smoke and hospital usage in Tasmania (2020)$10,000

Description: Poor air quality (indoor and outdoor) has been shown to increase morbidity in populations and as a result increase use of health resources. This study will evaluate the association between bush fire-smoke/ wood-smoke and hospital use in Tasmania.
Funding: Royal Hobart Hospital Research Foundation ($10,000)
Scheme: Grant-Incubator
Administered By: University of Tasmania
Research Team: Johnston F; de Graaff B; Palmer AJ; Harkness N; Walters EH
Year: 2020

Evaluation of the Tasmanian Elective Surgery Panel Project (2019)$9,980

Description: In 2015, the Tasmanian State Government allocated additional funds to reduce the public hospital elective surgery waiting lists. A subset of waitlisted patients was 'fast-tracked' for elective surgery to hospitals in Tasmania and Victoria. This project will evaluate the outcomes of this initiative.
Funding: Royal Hobart Hospital Research Foundation ($9,980)
Scheme: Grant-Incubator
Administered By: University of Tasmania
Research Team: de Graaff B; Song J; Hensher M; Campbell JA; Glading JA; Palmer AJ
Year: 2019

ANCHOR Project: heAlth ecoNomics and epidemiology of myalgiC encephalomyelitis/ chronic fatigue syndrome (2019 - 2021)$155,000

Funding: Medical Research Future Fund ($155,000)
Scheme: Grant - Targeted Health System and Community
Administered By: University of Tasmania
Research Team: de Graaff B; Campbell JA; Nicholl H; Hensher M; Wills KE; Palmer AJ
Period: 2019 - 2021

The Royal Hobart Hospital's innovative Rapid Access Chest Pain Clinic (RACPC): A health economic evaluation of patient, RHH and community benefits (2019)$24,952

Description: The overall aim of this project is to conduct a comprehensive health economic evaluation of the RHH's cutting-edge Rapid Access Chest Pain Clinic (RACPC) patient care model, compared to the usual care General Cardiology (GCC) clinic model for RHH patients with newly presented chest pain. The RACPC commenced in June 2014 and has realised positive clinical outcomes for its patients. Our comprehensive health economic investigation will build on the clinical work to systematically evaluate the health economic benefits of this innovative model's patient pathways for people who present to the RHH's Emergency Department (approximately 70%) or by referral from a primary care physician (approximately 30%) with new onset chest pain.
Funding: Royal Hobart Hospital Research Foundation ($24,952)
Scheme: Grant-Project
Administered By: University of Tasmania
Research Team: Campbell JA; Black JA; Palmer AJ; Sharman JE; Hensher M; de Graaff B
Year: 2019

Lead Support Coordinator Service (LSCS) Evaluation (2018)$99,999

Description: The LSCS trials a new model of coordinated care for clients with complex needs . Three community service organisations, Australian Red Cross, Mission Australia and Baptcare will employ 12 Lead service. Coordinators to provide the service to a maximum of 30 Tasmanians with multiple service needs. Clients will work with the coordinator to identify needs and match them to available services. The evaluation aims to test if this model of coordination leads to better health and wellbeing outcomes for the clients and more efficient and cost effective service delivery.
Funding: Department of Health and Human Services Tasmania ($99,999)
Scheme: Contract Research
Administered By: University of Tasmania
Research Team: Doherty BT; Nash RE; Elmer SL; de Graaff B; Julian RD; Campbell JA; Palmer AJ
Year: 2018

Reducing the Burden of Liver Cancer for Tasmanians (2018)$350,000

Description: Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer and is the third leading cause of cancer deaths internationally. It occurs most commonly amongst patients with cirrhosis of the liver, which is often caused by chronic infections with the hepatitis B and/or hepatitis C viruses. The clinical outcomes for patients diagnosed with HCC are highly dependent of the stage at which it is detected. Late detection is associated with significant morbidity and mortality. If detected early, HCC is potentially curable.Screening programs have been suggested to increase the rate of early diagnosis for at-risk groups. In Australia, current guidelines recommend HCC screening for all patients with cirrhosis, regardless of liver disease severity or aetiology. Screening consists of 6-monthly liver ultrasound and alpha-fetoprotein tests. Uptake of screening for HCC is very low in Australia, evidenced by the 5-year survival rate of just 17%. The aims of this project are to a) evaluate current uptake and adherence of HCC screening across Tasmania, b) develop strategies aimed at supporting at-risk patients to participate in regular HCC screening, c) evaluate the cost-effectiveness of screening interventions, and d) assess the effectiveness of new treatments for hepatitis C in reducing the rate of HCC in Tasmania.
Funding: Sefton Bottomley Liver Cancer Bequest ($350,000)
Scheme: Donation - Individual
Administered By: University of Tasmania
Research Team: de Graaff B; Palmer AJ; Yee KC; Cocker FM
Year: 2018

GP Assist (2017)$60,000

Description: Ongoing evaluation of the 'value-for-money' of the GP Assist after-hours telephone support service for Primary Health Tasmania.
Funding: Primary Health Tasmania ($60,000)
Scheme: Contract Research
Administered By: University of Tasmania
Research Team: de Graaff B; Neil A; Nelson MR
Year: 2017

Research Supervision

Current

Completed

Current

Degree	Title	Commenced
PhD	Co-ordination of Care for Complex Patients in Primary Care Settings: What works for whom and why?	2019
PhD	Using Data Linkage to Estimate the Burden of Diabetes in Tasmania	2019
PhD	ANCHOR Project: health economics and epidemiology of myalgic ecephalomyelitis	2020
PhD	The Long-Term Survival Impact on Distal Gastrectomy Versus Total Gastrectomy in Patients with Non-Metastatic Gastric Cancer	2020
PhD	Hospital Acquired Complications in Tasmania: prevalence and health economic implications	2022
PhD	Eliminating hepatitis B in remote Indigenous settings: generating health economic evidence	2023

Completed

Degree	Title	Completed
PhD	Health Economics Aspects of Primary Liver Cancer in Australia Candidate: Anh Le Tuan Nguyen	2022
PhD	Assessing the Burden and Economic Impact of Idiopathic Pulmonary Fibrosis in Australia Candidate: Ingrid Adamina Eve Cox	2022
PhD	Health Economics of Bariatric Surgery Candidate: Qing Xia	2022
PhD	Investigating the Evolution of Model-based Health Economic Evaluations and Changes in Health-related Quality of Life in Osteoarthritis Candidate: Ting Zhao	2021
Masters	The Demographic and Clinical Characteristics of Primary Liver Cancer Patients in Tasmania Candidate: Thi Thu Hoa Nguyen	2021
PhD	Trends of Australian Emergency Department Care for People with Mental Health Diagnoses: Implications for service provision and policy development Candidate: Quang Nhat Tran	2021
PhD	The Health Economics of Obesity in Adult Populations in Ghana Candidate: Stella Twumwaa Lartey	2020